Literature DB >> 27388112

Impact of the bacteriology of diabetic foot ulcers in limb loss.

Carlos A Hinojosa1, Estefania Boyer-Duck2, Javier E Anaya-Ayala2, Ana Nunez-Salgado2, Hugo Laparra-Escareno2, Adriana Torres-Machorro2, Rene Lizola2.   

Abstract

Infections in feet of patients with diabetes mellitus is common, complex and costly. The aim of this study to investigate the isolated microorganisms in infected diabetic foot ulcers, and the impact of these infectious agents in limb loss in a tertiary medical center in Mexico City. We conducted a retrospective review in diabetic patients with infected foot ulcers from 1997 to 2014. Diabetic foot was defined according to the World Health Organization (WHO), the bacteriology of wound cultures and the impact of microorganisms in limb loss (major amputation) was studied. Patient's demographics, comorbidities, wound characteristics, and other factors associated in clinical outcomes were determined. A total of 165 subjects with soft tissue infections and/or osteomyelitis and positive cultures were included. One hundred and five (64%) were male, with a mean age of 60 year old +/- 15. One hundred fifty-nine (96%) had Type 2 diabetes mellitus, 68 (41%) history of peripheral arterial disease (PAD) and 97 (59%) patients had osteomyelitis. In 89 patients (54%), cultures were polymicrobial and one single organism was isolated in 76 cultures (46%). During the follow up, 96 (58%) patients preserved their limbs and 69 (42%) required major amputation (above or below knee). Sixty percent of patients that suffered from limb loss had polymicrobial culture (p = 0.13). Growth of Escherichia coli and Enterococcus faecium (p = 0.03) and E. coli and Morganella morgagnii (p = 0.03) was associated to limb loss. Among monomicrobial cultures, infections associated with Proteous mirabilis had higher rate of progression to limb loss (p = 0.03). PAD was associated to limb loss (p = 0.001). Management of diabetic foot requires a multimodality approach. In this study, in patients that received appropriate antibiotic therapy and optimal surgical management, we observed that history of PAD, polymicrobial and isolated P. mirabilis infections were variables associated with higher rate of limb loss.
© 2016 by the Wound Healing Society.

Entities:  

Year:  2016        PMID: 27388112     DOI: 10.1111/wrr.12462

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  5 in total

1.  Polymicrobial Foot Infection Patterns Are Common and Associated With Treatment Failure.

Authors:  Neal R Barshes; Nicholas J Clark; Deeksha Bidare; J H Dudenhoeffer; Cezarina Mindru; Maria C Rodriguez-Barradas
Journal:  Open Forum Infect Dis       Date:  2022-09-15       Impact factor: 4.423

2.  Antimicrobial Susceptibility Testing and Phenotypic Detection of MRSA Isolated from Diabetic Foot Infection.

Authors:  Khanda Anwar; Dlsoz Hussein; Jamal Salih
Journal:  Int J Gen Med       Date:  2020-12-02

3.  Risk factors for amputation in patients with diabetic foot infection: a prospective study.

Authors:  Serhat Uysal; Bilgin Arda; Meltem I Taşbakan; Şevki Çetinkalp; Ilgın Y Şimşir; Anıl M Öztürk; Ayşe Uysal; İlgen Ertam
Journal:  Int Wound J       Date:  2017-07-19       Impact factor: 3.315

4.  Human myiasis in patients with diabetic foot: 18 cases.

Authors:  Serhat Uysal; Anil Murat Ozturk; Meltem Tasbakan; Ilgin Yildirim Simsir; Aysegul Unver; Nevin Turgay; Husnu Pullukcu
Journal:  Ann Saudi Med       Date:  2018 May-Jun       Impact factor: 1.526

Review 5.  Interplay between ESKAPE Pathogens and Immunity in Skin Infections: An Overview of the Major Determinants of Virulence and Antibiotic Resistance.

Authors:  Gustavo Henrique Rodrigues Vale de Macedo; Gabrielle Damasceno Evangelista Costa; Elane Rodrigues Oliveira; Glauciane Viera Damasceno; Juliana Silva Pereira Mendonça; Lucas Dos Santos Silva; Vitor Lopes Chagas; José Manuel Noguera Bazán; Amanda Silva Dos Santos Aliança; Rita de Cássia Mendonça de Miranda; Adrielle Zagmignan; Andrea de Souza Monteiro; Luís Cláudio Nascimento da Silva
Journal:  Pathogens       Date:  2021-02-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.